J&J commits more than $1 billion to a next-generation cell therapy plant in Montgomery County, Pennsylvania

Johnson & Johnson announced a manufacturing investment of more than $1 billion in a next-generation cell therapy facility in Montgomery County, Pennsylvania. The company expects more than 500 skilled biomanufacturing jobs once the site is fully operational and more than 4,000 construction jobs during build-out. The plant is part of the broader $55 billion U.S. investment plan, and the release gives no start-up date.

• Investment of more than $1 billion in a next-generation cell therapy manufacturing facility
• More than 500 skilled biomanufacturing jobs when fully operational
• More than 4,000 construction jobs during site development
• Part of the $55 billion U.S. investment plan through early 2029